FDA Approves Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Tablets For The Treatment Of HIV Infection

FDA Approves Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate)

US FDA gave green signal to Symfi Tablets For The Treatment Of HIV Infection

Mylan Pharmaceutical Inc.receives FDA approval for Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets for the treatment of HIV infection.

Company: Mylan Pharmaceutical Inc.

Brand Name: Symfi

Dosage Form: Capsule

Generic Name: efavirenz, lamivudine and tenofovir disoproxil fumarate

Dosage Form: Tablets

Treatment For: HIV Infection

 

 

General information about Symfi

Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) is a three-drug combination of a non-nucleoside reverse transcriptase inhibitor (efavirenz), and two nucleo(t)side reverse transcriptase inhibitors (lamivudine and tenofovir disoproxil fumarate) indicated as a complete regimen for the treatment of human immunodeficiency virus type 1(HIV) infection.

 

 

Our App

Contact Us

Address : 4216/20, Ground Floor, 1 Ansari Road, Daryaganj, New Delhi - 110002 (India)

[email protected]

QQ : [email protected]

Phone : +91-11-43526658

Mobile : +91-9873336444

Skype : Oddway2010

WeChat : Oddway2010

WhatsApp : +91-9873336444

Viber : +91-9873336444

Oddway International is a Pharmaceutical Exporter & Supplier of Generic Medicine and Online Pharmacy Distributor in India...Read More